The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology
Open accessAbstract
Down-regulation of protein phosphatase 2A (PP2A) is thought to play a critical role in tau hyperphosphorylation in Alzheimer's disease (AD). In vitro phosphorylation of PP2A catalytic subunit at Y307 efficiently inactivates PP2A. A specific antibody against phosphorylated (p) PP2A (Y307) (PP2Ac-Yp307) was used to investigate possible PP2A down-regulation by known pathophysiological changes associated with AD, such as Abeta accumulation and oestrogen deficiency. Immunohistochemistry and immunofluorescence confocal microscopy showed an aberrant accumulation of PP2Ac-Yp307 in neurons that bear pretangles or tangles in the susceptible brain regions, such as the entorhinal cortical cortex and the hippocampus. Experimentally, increased PP2Ac-Yp307 was observed in mouse N2a neuroblastoma cells that stably express the human amyloid precursor protein with Swedish mutation (APPswe) compared with wild-type, and in the brains of transgenic APPswe/ presenilin (PS1, A246E) mice, which corresponded to the increased tau phosphorylation. Treating N2a cells with Abeta25-35 mimicked the changes of PP2Ac-Yp307 and tau phosphorylation in N2a APPswe cells. Knockout of oestrogen receptor (ER) alpha or ERbeta gave similar changes of PP2Ac-Yp307 level and tau phosphorylation in the mouse brain. Taken together, these findings suggest that increased PP2A phosphorylation (Y307) can be mediated by Abeta deposition or oestrogen deficiency in the AD brain, and consequently compromise dephosphorylation of abnormally hyperphosphorylated tau, and lead to neurofibrillary tangle formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We have reported that Y307 phosphorylation of PP2A was increased in AD and contributed to PP2A inhibition (Liu et al., 2008).”
From CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer’s Disease (2018) · cites this paper as Liu et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ghribi, O., Pramoonjago, P., Herman, M. M., Spaulding, N. K., & Savory, J. (2003) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.09.001 · Cited by 33
RetractedJanssens, V., & Goris, J. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3530417 · Cited by 1,927
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611
Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils
Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526
Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478
Janssens, V., & Goris, J. (2001) · Biochemical Journal · doi:10.1042/bj3530417 · Cited by 1,392
Oddo, S., Billings, L., Kesslak, J. P., Cribbs, D. H., & LaFerla, F. M. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.003 · Cited by 780
Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation
Chen, J., Martin, B. L., & Brautigan, D. L. (1992) · Science · doi:10.1126/science.1325671 · Cited by 601
Phosphoprotein Phosphatase Activities in Alzheimer Disease Brain
Gong, C., Singh, T. J., Grundke‐Iqbal, I., & Iqbal, K. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03603.x · Cited by 527
Wang, Q., Walsh, D. M., Rowan, M. J., Selkoe, D. J., & Anwyl, R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1633-03.2004 · Cited by 437
Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity.
Takashima, A., Noguchi, K., Sato, K., Hoshino, T., & Imahori, K. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7789 · Cited by 385
Protein phosphatase 2A: a panoply of enzymes
Virshup, D. M. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)00074-5 · Cited by 330
Gender differences in the amount and deposition of amyloidβ in APPswe and PS1 double transgenic mice
Wang, J., Tanila, H., Puoliväli, J., Kadish, I., & Groen, T. V. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.009 · Cited by 316
Self-citationAn, W.-L., Cowburn, R. F., Li, L., Braak, H., Alafuzoff, I., Iqbal, K., Iqbal, I.-G., Winblad, B., & Pei, J.-J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63687-5 · Cited by 312
Self-citationStein, T. D., & Johnson, J. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-17-07380.2002 · Cited by 290
PP2A mRNA Expression Is Quantitatively Decreased in Alzheimer's Disease Hippocampus
Vogelsberg-Ragaglia, V., Schuck, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7630 · Cited by 281
Chen, J., Parsons, S., & Brautigan, D. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37144-2 · Cited by 259
Singh, M., Sétáló, G., Guan, X., Frail, D. E., & Toran‐Allerand, C. D. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-05-01694.2000 · Cited by 250
Sontag, E., Luangpirom, A., Hladik, C., Mudrak, I., Ogris, E., Speciale, S., & White, C. L. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.4.287 · Cited by 228
Wang, L., Andersson, S., Warner, M. N., & Gustafsson, J.-Α. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242735799 · Cited by 222
Self-citationUp-regulation of inhibitors of protein phosphatase-2A in Alzheimer’s disease
Tanimukai, H., Grundke-Iqbal, I., & Iqbal, K. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62486-8 · Cited by 220
Mannella, P., & Brinton, R. D. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1443-06.2006 · Cited by 213
Kins, S., Crameri, A., Evans, D. R. H., Hemmings, B. A., Nitsch, R. M., & Götz, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102621200 · Cited by 203
Sontag, E., Hladik, C. L., Montgomery, L. G., Luangpirom, A., Mudrak, I., Ogris, E., & White, C. L. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.10.1080 · Cited by 195
Role of protein kinase B in Alzheimer's neurofibrillary pathology
Pei, J.-J., Khatoon, S., An, W., Nordlinder, M., Tanaka, T., Braak, H., Tsujio, I., Takeda, M., Alafuzoff, I. I., Winblad, B. G., et al. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0657-y · Cited by 169
Self-citationIncreased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain
SWATTON, J. E., Sellers, L. A., Faull, R. L. M., Holland, A. J., Iritani, S., & Bahn, S. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03365.x · Cited by 158
Kins, S., Kurosinski, P., Nitsch, R. M., & Götz, J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63444-x · Cited by 155
Yu, X., Rajala, R. V. S., McGinnis, J. F., Li, F., Anderson, R. E., Yan, X., Li, S., Elias, R. V., Knapp, R. R., Zhou, X., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313283200 · Cited by 143
Self-citationPei, J.-J., Gong, C., An, W., Winblad, B. G., Cowburn, R. F., Grundke, I., & Iqbal, K. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63445-1 · Cited by 142
Self-citationTau protein I is essential for amyloid β-protein iduced neurotoxicity
Takashima, A. (1993) · Medical Entomology and Zoology · Cited by 125
Xie, H., & Clarke, S. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42124-7 · Cited by 123
Chung, H., Nairn, A. C., Murata, K., & Brautigan, D. L. (1999) · Biochemistry · doi:10.1021/bi990902g · Cited by 90
Fan, X., Warner, M. N., & Gustafsson, J.-Α. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609663103 · Cited by 84
Self-citationHeikkinen, T., Kalesnykas, G., Rissanen, A., Tapiola, T., Iivonen, S., Wang, J., Chaudhuri, J. D., Tanila, H., Miettinen, R. A., & Puoliväli, J. T. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.015 · Cited by 79
Self-citationYin, K., Hsu, C. Y., Hu, X.-Y., Chen, H., Chen, S.-W., Xu, J., & Lee, J. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.5103-05.2006 · Cited by 65
Flicking the switches: phosphorylation of serine/threonine protein phosphatases
Brautigan, D. L. (1995) · Seminars in Cancer Biology · doi:10.1006/scbi.1995.0028 · Cited by 65
Zhou, X., Li, X., Björkdahl, C., Sjögren, M. J. C., Alafuzoff, I. I., Soininen, H. S., Grundke, I., Iqbal, K., Winblad, B. G., & Pei, J.-J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.006 · Cited by 65
Self-citationPei, J. ‐., Gong, C., Iqbal, K., Grundke, I., Wu, Q., Winblad, B. G., & Cowburn, R. F. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050039 · Cited by 60
Self-citationPhosphorylation of tau at THR212 and SER214 in human neuronal and glial cultures: The role of AKT
Pyo, H. K., Lovati, E., Pasinetti, G. M., & Ksiȩżak-Reding, H. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.036 · Cited by 40
Wang, J., Tanila, H., Puoliväli, J. T., Kadish, I., & van Groen, T. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.02.006 · Cited by 34
Self-citationLiu, R., Pei, J.-J., Wang, X., Zhou, X., Tian, Q., Winblad, B. G., & Wang, J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03270.x · Cited by 31
Self-citation
Cited by
Sorted by citations
Post-translational modifications of tau protein: Implications for Alzheimer's disease
Martin, L., Latypova, X., & Terro, F. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2010.12.023 · Cited by 683
Wang, J., Xia, Y., Grundke, I., & Iqbal, K. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129031 · Cited by 547
Self-citationLiu, F., Shi, J., Tanimukai, H., Gu, J., Gu, J., Grundke-Iqbal, I., Iqbal, K., & Gong, C.-X. (2009) · Brain · doi:10.1093/brain/awp099 · Cited by 439
The Role of Tau in Alzheimer's Disease and Related Disorders
Medeiros, R., Baglietto‐Vargas, D., & LaFerla, F. M. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00177.x · Cited by 484
Wang, H., Sui, H., Zheng, Y., Jiang, Y., Shi, Y., Liang, J., & Zhao, L. (2019) · Nanoscale · doi:10.1039/c9nr01255a · Cited by 324
Metadata
- Authors
- Liu, R., Zhou, X. ‐., Tanila, H., Bjorkdahl, C., Wang, J. ‐., Guan, Z. ‐., Cao, Y., Gustafsson, J. ‐., Winblad, B., & Pei, J. ‐.
- Affiliations
- Karolinska Institutet (SE)
- University of Eastern Finland (FI)
- Huazhong University of Science and Technology (CN)
- Guiyang Medical University (CN)
- Corresponding author
- Liu, R.
- Venue
- Journal of Cellular and Molecular Medicine
- Publisher
- Wiley
- Published
- 2008-01
- Volume
- 12
- Issue
- 1
- Pages
- 241-257
- ISSN
- 1582-1838 (ISSN-L)
- 1582-4934
- PMC
- PMC3823485
- OpenAlex
- W1995042713
- Cited by
- 125
- References
- 41
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 5 · 2022: 8 · 2021: 5 · 2020: 8 · 2019: 8 · 2018: 8 · 2017: 4 · 2016: 3 · 2015: 3 · 2014: 11 · 2013: 10 · 2012: 12
- FWCI
- 8.35
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Cellular and Molecular Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- protein phosphatase 2A, Alzheimer's disease, neurofibrillary tangles, tau hyperphosphorylation, amyloid-beta, estrogen deficiency, estrogen receptor alpha, estrogen receptor beta, APPswe, presenilin 1, entorhinal cortex, hippocampus, N2a cells
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Animals, Antibodies, Monoclonal, Estrogens, Female, Humans, Male, Mice, Transgenic, Mutation, Neuroblastoma, Neurons, Phosphorylation, Transfection, Tyrosine, Amyloid beta-Protein Precursor, Neurofibrillary Tangles, tau Proteins, Microscopy, Confocal, Fluorescent Antibody Technique, Indirect, Estrogen Receptor alpha, Estrogen Receptor beta, Mice, Protein Phosphatase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review